Cargando…
Detecting SARS-CoV-2 Orf3a and E ion channel activity in COVID-19 blood samples
BACKGROUND: SARS-CoV-2 has been found in the heart of COVID-19 patients. It is unclear how the virus passes from the upper respiratory tract to the myocardium. We hypothesized that SARS-CoV-2 is present in the blood of COVID-19 infected patients, spreading to other organs such as heart. METHODS: We...
Autores principales: | Yu, Han-Gang, Sizemore, Gina, Smoot, Katy, Perrotta, Peter |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8632412/ https://www.ncbi.nlm.nih.gov/pubmed/34873451 http://dx.doi.org/10.1017/cts.2021.856 |
Ejemplares similares
-
Inhibition of SARS-CoV-2 Viral Channel Activity Using FDA-Approved Channel Modulators Independent of Variants
por: Yu, Han-Gang, et al.
Publicado: (2022) -
ORF8a of SARS-CoV forms an ion channel: Experiments and molecular dynamics simulations
por: Chen, Cheng-Chang, et al.
Publicado: (2011) -
The SARS-CoV-2 accessory protein Orf3a is not an ion channel, but does interact with trafficking proteins
por: Miller, Alexandria N, et al.
Publicado: (2023) -
ORF8/ORF8a: a difference between SARS-CoV-2 and SARS-CoV
por: Zandi, Milad
Publicado: (2022) -
SARS-CoV-2 ORF8 and SARS-CoV ORF8ab: Genomic Divergence and Functional Convergence
por: Mohammad, Sameer, et al.
Publicado: (2020)